Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo

[1]  K. Ulbrich,et al.  Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers , 1991 .

[2]  K. Ulbrich,et al.  N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. , 1991, British Journal of Cancer.

[3]  D. Sgouras,et al.  Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1 — Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation ofin vitro cytotoxicity , 1990 .

[4]  K. Ulbrich,et al.  The pharmacokinetics of polymer-bound adriamycin. , 1990, Biochemical pharmacology.

[5]  K. Ulbrich,et al.  Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycin , 1989 .

[6]  K. Ulbrich,et al.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo , 1989 .

[7]  K. Ulbrich,et al.  Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. , 1989, Biomaterials.

[8]  J. Kopeček,et al.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. , 1988, British Journal of Cancer.

[9]  K. Ulbrich,et al.  Polymer-bound derivatives of sarcolysin and their antitumour activity against mouse and human leukaemia in vitro , 1987 .

[10]  V. Šubr,et al.  Degradation of Oligopeptide Sequences Connecting Poly[N-(2- hydroxypropyl)methacrylamide] Chains by Lysosomal Cysteine Proteinases , 1986 .

[11]  J. Kopeček,et al.  Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. , 1985, Biomaterials.

[12]  Jindřich Kopeček,et al.  Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N‐(2‐hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B , 1983 .

[13]  J. Kopeček,et al.  Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. , 1983, Biochimica et biophysica acta.

[14]  J. Kopeček,et al.  Degradation of side-chains ofN-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases , 1982, Bioscience reports.

[15]  J. Kopeček,et al.  Polymers containing enzymatically degradable bonds, 1. Chymotrypsin catalyzed hydrolysis of p‐nitroanilides of phenylalanine and tyrosine attached to side‐chains of copolymers of N‐(2‐hydroxypropyl)methacrylamide , 1981 .

[16]  T. Boat,et al.  An improved method for the determination of galactosaminitol, glucosaminitol, glucosamine, and galactosamine on an amino acid analyzer. , 1978, Analytical biochemistry.

[17]  G. Fasman,et al.  Synthesis and conformational studies of model histones. Sequential and random polypeptides with the composition L-lysyl-L-alanyl-glycine. , 1974, Biochemistry.

[18]  K. Brocklehurst,et al.  A novel reactivity of papain and a convenient active site titration in the presence of other thiols , 1970, FEBS letters.

[19]  A. Berger,et al.  On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. , 1968, Biochemical and biophysical research communications.